• Men’s health: year-round prostate cancer screening; listen up
• Pernambuco Cancer Hospital opens facility in Recife
O government of Pernambuco launched, this Monday (12), the validation tests of the National Molecular Biology Kit for detection of cervical cancer. The initiative is in partnership with Recife Secretariat of Health and the Pan American Health Organization (PAHO/WHO). With a low cost, the test has the ability to identify the DNA of the Human Papillomavirus (HPV). In the state, the disease makes 300 women of victims per annum.
During the morning of this Monday, 16 patients underwent the collection of gynecological material at Upinha Fernanda Wanderley, in the neighborhood of Linha do Tiro, in the North Zone of Recife.
Currently, most preventive collections for the detection of cervical cancer in Brazil are performed in women through the cytopathological examination, popularly known as Pap smear. The new platform uses the same technology used in Covid-19 detection exams, through the RT-PCR. This analysis that identifies HPV through DNA has faster results – Pap smears come out, on average, in 30 days, and those by PCR Test, in 15. In addition, the Kit is more sensitive and effective in diagnosis. All this with a value that can be absorbed by the Unified Health System (SUS).
The new test is part of the “Uterus is Life” Program, which aims to reduce the numbers of cervical cancer in the state. For the validation of the National Kit at the National Health Surveillance Agency (Anvisa) a total of 1,500 tests will be carried out in the coming days. Another eight units from Districts II and VII of Recife, plus Upinha Fernanda Wanderley, participate in this phase of work. In the second stage, after Anvisa’s release, the National Kit can be used on a large scale in Pernambuco.
During the launch, the State Secretary of Health, André Longo, highlighted the involvement of national and international entities in the “Uterus is Life” Program. “Several institutions came together to change the scenario of cervical cancer in Pernambuco and Brazil. This kit allows a diagnosis with greater security, generating greater convenience for the woman. If her test is negative, for example, that woman will only need to be tested again every five years. The development of this national kit will be a differential in the diagnosis of this disease, which kills one woman a day in Pernambuco”, said André Longo.
PAHO/WHO Representative in Brazil, Socorro Gross explained that the success of the Kit tests is aligned with a perspective that goes beyond the borders of Pernambuco. “The hardest thing we have is the diagnosis. If we don’t have a diagnosis that is right, accessible to our countries and accepted by our women, we can’t make a diagnosis that we need for cancer that is curable. Therefore, the test is relevant not only for Pernambuco, but for the entire health system in Brazil and Pan-American countries”, emphasized Socorro Gross.
The PAHO leader also emphasized the representativeness of this new step of “Uterus is Life” for women. “The cost of testing with other kits is very high. And this kit, which is more affordable, will improve the line of care for cervical cancer so that it can be eliminated as a public health problem. It is an initiative that goes to women and the family. When a woman stops dying from a cancer that takes a long time to be diagnosed, that can be prevented, I feel represented as a woman,” she concluded.
NASA again postpones launch of its new rocket to the moon
STF has five votes to maintain suspension of the nursing floor
#Pernambuco #validates #RTPCR #test #detection #Cervical #Cancer